DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Citichem India Ltd (CITICHEM) share price today?

Citichem India Ltd (CITICHEM) is trading at ₹16 on the BSE, down 2.44% on the day. Source: DocStoX.

What is the PE ratio of Citichem India Ltd?

Citichem India Ltd has a price-to-earnings (PE) ratio of 8.8 in the Commodities sector.

What is the market capitalisation of Citichem India Ltd?

Citichem India Ltd has a market capitalisation of approximately ₹11 crore.

Citichem India Ltd

CITICHEM·BSE·Commodities

₹16.00▼ -0.40 (-2.44%)

Commodities · Chemicals & Petrochemicals

A steady, established business

52W₹12

₹3121%

Open

₹16.00

High

₹16.00

Low

₹16.00

Prev Close

₹16.40

Volume

2.0K

VWAP

₹16.00

Snapshot

Key fundamentals

Market Cap

₹11 Cr

P/E Ratio

8.84Cheap

P/B Ratio

0.52

EPS

₹1.81

Book Value

₹31.03

ROE

4.85%Weak

ROCE

11.56%Decent

Dividend Yield

0.00%

Debt / Equity

0.37Moderate

Face Value

₹10.00

52W High

₹31.00

52W Low

₹12.00

Sector

Commodities

Industry

Chemicals & Petrochemicals

Buy

None moatHigh uncertainty

Fair value estimate

₹29

▲ 82.7%upside

Trading at ₹16 — 83% below our estimate

BearFair valueBull

₹25₹29₹34

/100

Business quality — Watch the fundamentals

Growth 50Profitability 1Efficiency 18Valuation 91

Plain English

Our view

A steady, established business
Low debt relative to equity
Weak returns on equity (5%)

Strengths

Low debt relative to equity
Reasonably priced at 9× earnings
Promoters hold a controlling stake

Risks

Weak returns on equity (5%)

How we got there

Fair value methods

Residual income

6% ROE fading to 14% over ~3 yrs, on ₹31 book

₹28

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹32

Analyst target

No analyst coverage

—

Blended fair value₹29

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Reasonably priced at 9× earnings
Promoters hold a controlling stake

Bear case

Weak returns on equity (5%)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

8.8Cheap

Below 15× is value territory; above 35× prices in strong growth

ROE

4.8%Weak

Above 15% is considered healthy for Indian equities

ROCE

11.6%Decent

Above 18% means capital is working hard

Debt/Eq

0.37Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹11 Cr

P/B

0.52

EPS

₹1.81

Div Yield

—

What changed

Recent changes

Promoters+0.33% stake last quarter

What matters

News impact

Overview

Valuation

Attractive

P/E 8.8×

Growth

Shrinking

-23% rev CAGR

Profitability

Modest

4.8% ROE

Financial health

Comfortable

D/E 0.37

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹32,000 Cr

Trades1

VWAP₹16.00

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

-23.2%

-44.5%

10Y

—

Profit

+41.5%

+35.9%

10Y

—

EPS

+26.9%

—

10Y

—

Profile

Pros

Stock is trading at 0.52 times its book value

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of -39.4% over past five years.
Company has a low return on equity of 8.78% over last 3 years.
Contingent liabilities of Rs.21.4 Cr.
Earnings include an other income of Rs.0.70 Cr.
Company has high debtors of 918 days.
Working capital days have increased from 164 days to 289 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 0.33 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

62%

Promoter

Promoters

61.5%+0.33

Public

29.6%-0.50

FII / FPI

0.0%0.00

DII

0.0%0.00

Others

8.8%

Total shareholders

605-70 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter61.54%

Public29.64%

Others8.82%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1992, Citichem India Ltd is in the business of trading of chemicals.[1]